For Physicians For Patients
Text Size: A A A
Facebook LinkedIn
American Health Network

New Albany

For more information, please call us at 317-718-5482 or 877-340-7291.


Type 2 Diabetes Mellitus

This is a Phase 3 study to evaluate the effect of Efpeglenatide on cardiovascular outcomes in type 2 diabetes patients at high cardiovascular risk. Visit for more information.

© Copyright 2019 AHN Target Holdings, LLC. All Rights Reserved.